エーザイの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/03/31 | 7,343 | 7,439 | 7,311 | 7,419 | -67 | -0.9% | 715,900 |
2021/03/30 | 7,629 | 7,629 | 7,437 | 7,486 | -80 | -1.1% | 610,800 |
2021/03/29 | 7,646 | 7,652 | 7,497 | 7,566 | +41 | +0.5% | 841,900 |
2021/03/26 | 7,362 | 7,610 | 7,355 | 7,525 | +212 | +2.9% | 1,013,500 |
2021/03/25 | 7,298 | 7,340 | 7,217 | 7,313 | +77 | +1.1% | 831,000 |
2021/03/24 | 7,380 | 7,380 | 7,220 | 7,236 | -213 | -2.9% | 859,300 |
2021/03/23 | 7,558 | 7,595 | 7,449 | 7,449 | -54 | -0.7% | 584,000 |
2021/03/22 | 7,527 | 7,538 | 7,431 | 7,503 | -119 | -1.6% | 828,000 |
2021/03/19 | 7,649 | 7,700 | 7,588 | 7,622 | -71 | -0.9% | 899,200 |
2021/03/18 | 7,629 | 7,748 | 7,610 | 7,693 | +72 | +0.9% | 755,600 |
2021/03/17 | 7,550 | 7,634 | 7,542 | 7,621 | +33 | +0.4% | 536,900 |
2021/03/16 | 7,482 | 7,600 | 7,460 | 7,588 | +59 | +0.8% | 903,000 |
2021/03/15 | 7,473 | 7,557 | 7,424 | 7,529 | +72 | +1% | 632,100 |
2021/03/12 | 7,382 | 7,457 | 7,329 | 7,457 | +39 | +0.5% | 1,266,800 |
2021/03/11 | 7,367 | 7,438 | 7,352 | 7,418 | +31 | +0.4% | 682,900 |
2021/03/10 | 7,342 | 7,494 | 7,320 | 7,387 | +117 | +1.6% | 833,200 |
2021/03/09 | 7,286 | 7,347 | 7,255 | 7,270 | +22 | +0.3% | 745,700 |
2021/03/08 | 7,290 | 7,345 | 7,211 | 7,248 | -7 | -0.1% | 669,700 |
2021/03/05 | 7,265 | 7,308 | 7,180 | 7,255 | +18 | +0.2% | 739,400 |
2021/03/04 | 7,384 | 7,388 | 7,183 | 7,237 | -163 | -2.2% | 815,900 |
2021/03/03 | 7,400 | 7,431 | 7,343 | 7,400 | +65 | +0.9% | 785,600 |
2021/03/02 | 7,350 | 7,394 | 7,286 | 7,335 | -70 | -0.9% | 745,000 |
2021/03/01 | 7,443 | 7,448 | 7,352 | 7,405 | +86 | +1.2% | 633,600 |
2021/02/26 | 7,600 | 7,601 | 7,310 | 7,319 | -278 | -3.7% | 1,305,300 |
2021/02/25 | 7,694 | 7,703 | 7,579 | 7,597 | -28 | -0.4% | 710,100 |
2021/02/24 | 7,775 | 7,775 | 7,613 | 7,625 | ±0 | ±0% | 1,021,000 |
2021/02/22 | 7,680 | 7,690 | 7,583 | 7,625 | -36 | -0.5% | 559,300 |
2021/02/19 | 7,708 | 7,738 | 7,623 | 7,661 | -77 | -1% | 701,700 |
2021/02/18 | 7,786 | 7,857 | 7,722 | 7,738 | +23 | +0.3% | 682,300 |
2021/02/17 | 7,799 | 7,830 | 7,702 | 7,715 | -67 | -0.9% | 437,500 |
2021/02/16 | 7,795 | 7,828 | 7,735 | 7,782 | -4 | -0.1% | 733,800 |
2021/02/15 | 7,760 | 7,814 | 7,712 | 7,786 | +6 | +0.1% | 586,100 |
2021/02/12 | 7,867 | 7,867 | 7,756 | 7,780 | -93 | -1.2% | 815,200 |
2021/02/10 | 7,776 | 7,879 | 7,715 | 7,873 | +79 | +1% | 637,300 |
2021/02/09 | 7,804 | 7,809 | 7,716 | 7,794 | -19 | -0.2% | 589,200 |
2021/02/08 | 7,680 | 7,845 | 7,634 | 7,813 | +148 | +1.9% | 989,200 |
2021/02/05 | 7,588 | 7,680 | 7,533 | 7,665 | +114 | +1.5% | 888,500 |
2021/02/04 | 7,660 | 7,680 | 7,523 | 7,551 | -84 | -1.1% | 733,500 |
2021/02/03 | 7,693 | 7,769 | 7,486 | 7,635 | -69 | -0.9% | 1,273,900 |
2021/02/02 | 7,706 | 7,760 | 7,652 | 7,704 | -89 | -1.1% | 1,022,200 |
2021/02/01 | 7,766 | 7,869 | 7,685 | 7,793 | +150 | +2% | 1,244,100 |
2021/01/29 | 7,720 | 7,765 | 7,628 | 7,643 | -66 | -0.9% | 977,700 |
2021/01/28 | 7,680 | 7,771 | 7,660 | 7,709 | -161 | -2% | 2,469,600 |
2021/01/27 | 7,863 | 7,926 | 7,827 | 7,870 | +69 | +0.9% | 1,087,200 |
2021/01/26 | 7,880 | 7,924 | 7,792 | 7,801 | -49 | -0.6% | 783,300 |
2021/01/25 | 7,795 | 7,888 | 7,714 | 7,850 | +217 | +2.8% | 1,169,700 |
2021/01/22 | 7,633 | 7,649 | 7,563 | 7,633 | -93 | -1.2% | 975,200 |
2021/01/21 | 7,579 | 7,738 | 7,570 | 7,726 | +166 | +2.2% | 1,265,400 |
2021/01/20 | 7,595 | 7,658 | 7,545 | 7,560 | -105 | -1.4% | 1,318,000 |
2021/01/19 | 7,669 | 7,699 | 7,628 | 7,665 | -15 | -0.2% | 910,700 |
1001~
1050
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「エーザイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
エーザイ | 427,100円 | +1.7% | -2.9% | 3.75% | 28.02倍 | 1.47倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 245,700円 | +5.7% | +3.9% | 2.50% | 12.22倍 | 1.62倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
協和キリン | 219,100円 | -3.5% | -11.3% | 2.74% | 20.12倍 | 1.35倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
小野薬 | 166,700円 | -3.1% | -63.4% | 4.80% | 15.66倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム